Rankings
▼
Calendar
RVMD Q3 2025 Earnings — Revolution Medicines, Inc. Revenue & Financial Results | Market Cap Arena
RVMD
Revolution Medicines, Inc.
$20B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$315M
Net Income
-$305M
EPS (Diluted)
$-1.61
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$207M
Free Cash Flow
-$211M
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$2.3B
Total Liabilities
$655M
Stockholders' Equity
$1.6B
Cash & Equivalents
$217M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$315M
-$176M
-79.4%
Net Income
-$305M
-$156M
-95.3%
← FY 2025
All Quarters
Q4 2025 →